Enanta Pharmaceuticals
ENTA
#7451
Rank
S$0.54 B
Marketcap
S$18.92
Share price
3.62%
Change (1 day)
76.46%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of June 2025 : S$0.10 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has S$0.10 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$S$0.16 B-44.09%
2023-09-30$S$0.29 B-35.81%
2022-09-30$S$0.46 B-14.98%
2021-09-30$S$0.54 B-12.74%
2020-09-30$S$0.62 B-2.74%
2019-09-30$S$0.63 B18.76%
2018-09-30$S$0.53 B31.28%
2017-09-30$S$0.41 B11.33%
2016-09-30$S$0.36 B9.55%
2015-09-30$S$0.33 B77.24%
2014-09-30$S$0.18 B36.79%
2013-09-30$S$0.13 B156.83%
2012-09-30$S$53.98 M89.33%
2011-09-30$S$28.51 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AbbVie
ABBV
-S$3.37 Billion-3,378.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$102.73 B 99,897.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$22.44 B 21,745.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$67.26 B 65,373.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$24.10 B 23,361.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$57.99 B 56,348.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland